Bioengineered Nanomedicines Targeting the Intestinal Fc Receptor Achieve the Improved Glucoregulatory Effect of Semaglutide in a Type 2 Diabetic Mice Model
AuthID
P-017-5P2
P-017-5P2
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service